Correlation Between Viking Therapeutics and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Viridian Therapeutics, you can compare the effects of market volatilities on Viking Therapeutics and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Viridian Therapeutics.
Diversification Opportunities for Viking Therapeutics and Viridian Therapeutics
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Viking and Viridian is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Viking Therapeutics and Viridian Therapeutics
Given the investment horizon of 90 days Viking Therapeutics is expected to under-perform the Viridian Therapeutics. In addition to that, Viking Therapeutics is 1.16 times more volatile than Viridian Therapeutics. It trades about -0.25 of its total potential returns per unit of risk. Viridian Therapeutics is currently generating about 0.0 per unit of volatility. If you would invest 2,217 in Viridian Therapeutics on August 31, 2024 and sell it today you would lose (30.00) from holding Viridian Therapeutics or give up 1.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viking Therapeutics vs. Viridian Therapeutics
Performance |
| Timeline |
| Viking Therapeutics |
| Viridian Therapeutics |
Viking Therapeutics and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viking Therapeutics and Viridian Therapeutics
The main advantage of trading using opposite Viking Therapeutics and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Viking Therapeutics vs. Cue Biopharma | Viking Therapeutics vs. Eliem Therapeutics | Viking Therapeutics vs. Inhibrx | Viking Therapeutics vs. Molecular Partners AG |
| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |